News for Healthier Living

Pilot Study Demonstrates Safety of Ifetroban for Patients With High-Risk Solid Tumors, Suggests Potential to Block Cancer Metastasis

Results from a pilot clinical trial conducted by Vanderbilt Health and Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on developing new products for rare diseases, confirm the safety of ifetroban and support the further development of the drug to prevent cancer metastasis.

June 2, 2026


June 2 2026

June 1 2026

May 31 2026

May 30 2026

May 29 2026

May 28 2026

May 27 2026

May 26 2026

May 25 2026

May 22 2026

May 21 2026

May 20 2026